These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2949064)

  • 1. Suppressor cell function in solid tumor cancer patients.
    Von Roenn J; Harris JE; Braun DP
    J Clin Oncol; 1987 Jan; 5(1):150-9. PubMed ID: 2949064
    [No Abstract]   [Full Text] [Related]  

  • 2. [Radiotherapy and antitumor immunity. Fundamentals of immunooncology].
    Klimovich VB
    Med Radiol (Mosk); 1982 Jun; 27(6):68-73. PubMed ID: 6213829
    [No Abstract]   [Full Text] [Related]  

  • 3. Modulatory and effector function of monocytes in heavy human Schistosomiasis mansoni.
    Olds GR; El Kholy A; Ellner JJ
    Trans Assoc Am Physicians; 1982; 95():120-5. PubMed ID: 6222532
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor immunology--three decades in review.
    Brodt P
    Annu Rev Microbiol; 1983; 37():447-76. PubMed ID: 6227278
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunomodulation by cancer chemotherapeutic agents and antineoplastic activity.
    Spreafico F; Mantovani A
    Pathobiol Annu; 1981; 11():177-95. PubMed ID: 6460217
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of subsets of lymphocytes infiltrating head and neck tumor tissue: a preliminary report.
    Rabin BS; Johnson J; Claassen D
    Laryngoscope; 1984 May; 94(5 Pt 1):688-90. PubMed ID: 6232437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lymphocyte subpopulations in malignant growths].
    Kadagidze ZG
    Vopr Onkol; 1984; 30(1):90-7. PubMed ID: 6198804
    [No Abstract]   [Full Text] [Related]  

  • 8. [T-cell neoplasms with helper or suppressor activity].
    Rupniewska ZM
    Acta Haematol Pol; 1981; 12(1):53-61. PubMed ID: 6458988
    [No Abstract]   [Full Text] [Related]  

  • 9. Human tumor-infiltrating lymphocytes: a marker of host response.
    Vose BM; Moore M
    Semin Hematol; 1985 Jan; 22(1):27-40. PubMed ID: 3155876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of antitumor natural killer cell-mediated defense in the brain.
    Yamasaki T
    Surg Neurol; 2004 Mar; 61(3):227-8. PubMed ID: 14984990
    [No Abstract]   [Full Text] [Related]  

  • 11. [Molecular mechanisms of tumor and immune system interaction].
    Berezhnoĭ AE; Gnuchev NV; Georgiev GP; Kozlov AM; Larin SS
    Vopr Onkol; 2008; 54(6):669-83. PubMed ID: 19241839
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigen-specific suppressor ("blocking") factors in tumor immunity.
    Hellström KE; Hellström I; Nelson K
    Biomembranes; 1983; 11():365-88. PubMed ID: 6219721
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogene therapy.
    Lichtor T; Glick RP
    Adv Exp Med Biol; 2012; 746():151-65. PubMed ID: 22639166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of leukemic pro-suppressor cells to become suppressor-effector cells. Influence of cooperating normal T cells.
    Broder S; Uchiyama T; Muul LM; Goldman C; Sharrow S; Poplack DG; Waldmann TA
    N Engl J Med; 1981 Jun; 304(23):1382-7. PubMed ID: 6453293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T gamma and T mu lymphocytes. Clinical and experimental studies of human T gamma and T mu lymphocytes participating in the immune response.
    Jensen JR
    Dan Med Bull; 1984 Apr; 31(2):73-89. PubMed ID: 6233103
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial retrospective. Human lymphocyte subpopulations in metastatic neoplasia--six years later.
    Robbins DS; Fudenberg HH
    N Engl J Med; 1983 Jun; 308(26):1595-7. PubMed ID: 6190084
    [No Abstract]   [Full Text] [Related]  

  • 17. [Subpopulations of human T-lymphocytes and their suppressor functions].
    Brondz BD
    Ter Arkh; 1980; 52(9):120-32. PubMed ID: 6449090
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of suppressive and activating glycoconjugates on lymphocytes].
    Fuks BB
    Vestn Akad Med Nauk SSSR; 1990; (2):39-42. PubMed ID: 2192515
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possible approaches to the study of the immunological status of cancer patients and healthy people].
    Montsevichiute-Eringene EV
    Eksp Onkol; 1984; 6(2):8-14. PubMed ID: 6391906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effector immune mechanisms in cancer.
    Lotzová E
    Nat Immun Cell Growth Regul; 1985; 4(6):293-304. PubMed ID: 3911064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.